Nepalese Researchers Identify Cost-Effective Treatment for Drug-Resistant Typhoid

New research carried out by researchers in Nepal has shown that a new and affordable drug, Gatifloxacin, may be more effective at treating typhoid fever than the drug currently recommended by the World Health Organisation. The study, funded by the Wellcome Trust, has implications for the treatment of typhoid particularly in areas where drug resistance is a major problem. The results are published today in the open access journal PLoS ONE.